Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

STACEY STEIN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1285824706
CMS profile
194230
Location
NEW HAVEN, CT

General Payments · PY2018–2024

$111,581.59

  • Reported across 126 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$17,523.97

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Regeneron Pharmaceuticals, Inc. $7,124.29 4
JAZZ PHARMACEUTICALS INC. $3,120.00 2
Acerta Pharma LLC $2,690.00 3
Merck Sharp & Dohme Corporation $2,440.00 1
GlaxoSmithKline, LLC. $1,450.00 1
Exelixis Inc. $660.00 1
Genentech, Inc. $39.68 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $28,744.19 42
PY2019 $19,734.19 31
PY2020 $4,584.64 4
PY2021 $8,066.90 6
PY2022 $16,270.42 12
PY2023 $16,657.28 18
PY2024 $17,523.97 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $525.00 03/06/2024 Consulting Fee Undisputed 01/23/2026 1105364522 CMS
AstraZeneca Pharmaceuticals LP $525.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 1105827119 CMS
AstraZeneca Pharmaceuticals LP $1,640.00 11/14/2024 Consulting Fee Undisputed 01/23/2026 1105703240 CMS
Exelixis Inc. $660.00 05/30/2024 Honoraria Undisputed 01/23/2026 1138565896 CMS
Genentech, Inc. $39.68 01/19/2024 Food and Beverage Undisputed 01/23/2026 1133115031 CMS
GlaxoSmithKline, LLC. $1,450.00 11/07/2024 Consulting Fee Undisputed 01/23/2026 1116590305 CMS
JAZZ PHARMACEUTICALS INC. $2,340.00 06/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1150207932 CMS
JAZZ PHARMACEUTICALS INC. $780.00 06/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1150207930 CMS
Merck Sharp & Dohme LLC $2,440.00 03/04/2024 Consulting Fee Undisputed 01/23/2026 1141723308 CMS
Regeneron Pharmaceuticals, Inc. $831.00 08/02/2024 Consulting Fee Undisputed 01/23/2026 1114405407 CMS
Regeneron Pharmaceuticals, Inc. $4,155.00 08/02/2024 Consulting Fee Undisputed 01/23/2026 1114405409 CMS
Regeneron Pharmaceuticals, Inc. $1,662.00 08/02/2024 Consulting Fee Undisputed 01/23/2026 1114405411 CMS
Regeneron Pharmaceuticals, Inc. $476.29 08/14/2024 Travel and Lodging Undisputed 01/23/2026 1114405413 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.